BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36272994)

  • 21. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates.
    Ling X; Chang L; Chen H; Gao X; Yin J; Zuo Y; Huang Y; Zhang B; Hu J; Liu T
    Mol Cell; 2021 Nov; 81(22):4747-4756.e7. PubMed ID: 34648747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and Prospective Applications of CRISPR-Cas12a in Pluricellular Organisms.
    Khan S; Sallard E
    Mol Biotechnol; 2023 Feb; 65(2):196-205. PubMed ID: 35939208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cas12a mediates efficient and precise endogenous gene tagging via MITI: microhomology-dependent targeted integrations.
    Li P; Zhang L; Li Z; Xu C; Du X; Wu S
    Cell Mol Life Sci; 2020 Oct; 77(19):3875-3884. PubMed ID: 31848638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds.
    Teng F; Li J; Cui T; Xu K; Guo L; Gao Q; Feng G; Chen C; Han D; Zhou Q; Li W
    Genome Biol; 2019 Feb; 20(1):15. PubMed ID: 30717767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized protocols for the characterization of Cas12a activities.
    Martin L; Rostami S; Rajan R
    Methods Enzymol; 2023; 679():97-129. PubMed ID: 36682874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting CRISPR-Cas12a guide efficiency for targeting using machine learning.
    O'Brien A; Bauer DC; Burgio G
    PLoS One; 2023; 18(10):e0292924. PubMed ID: 37847697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient genome editing by CRISPR-Mb3Cas12a in mice.
    Wang Z; Wang Y; Wang S; Gorzalski AJ; McSwiggin H; Yu T; Castaneda-Garcia K; Prince B; Wang H; Zheng H; Yan W
    J Cell Sci; 2020 May; 133(9):. PubMed ID: 32393674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
    Yang Z; Xu P
    Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Cas12a-mediated gene editing efficiency in plants.
    Bernabé-Orts JM; Casas-Rodrigo I; Minguet EG; Landolfi V; Garcia-Carpintero V; Gianoglio S; Vázquez-Vilar M; Granell A; Orzaez D
    Plant Biotechnol J; 2019 Oct; 17(10):1971-1984. PubMed ID: 30950179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted integration in human cells through single crossover mediated by ZFN or CRISPR/Cas9.
    Liu X; Wang M; Qin Y; Shi X; Cong P; Chen Y; He Z
    BMC Biotechnol; 2018 Oct; 18(1):66. PubMed ID: 30340581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precise genome-wide base editing by the CRISPR Nickase system in yeast.
    Satomura A; Nishioka R; Mori H; Sato K; Kuroda K; Ueda M
    Sci Rep; 2017 May; 7(1):2095. PubMed ID: 28522803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas12a system in fission yeast for multiplex genomic editing and CRISPR interference.
    Zhao Y; Boeke JD
    Nucleic Acids Res; 2020 Jun; 48(10):5788-5798. PubMed ID: 32374858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the plant genome editing toolbox with recently developed CRISPR-Cas systems.
    Wada N; Osakabe K; Osakabe Y
    Plant Physiol; 2022 Mar; 188(4):1825-1837. PubMed ID: 35099553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.
    Sundaresan R; Parameshwaran HP; Yogesha SD; Keilbarth MW; Rajan R
    Cell Rep; 2017 Dec; 21(13):3728-3739. PubMed ID: 29281823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Off-Target Effect of CRISPR-Cas12a System toward Insertions and Deletions between Target DNA and crRNA Sequences.
    Zhang W; Shi R; Dong K; Hu H; Shu W; Mu Y; Yan B; Li L; Xiao X; Wang H
    Anal Chem; 2022 Jun; 94(24):8596-8604. PubMed ID: 35670376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity.
    Huang H; Huang G; Tan Z; Hu Y; Shan L; Zhou J; Zhang X; Ma S; Lv W; Huang T; Liu Y; Wang D; Zhao X; Lin Y; Rong Z
    BMC Biol; 2022 Apr; 20(1):91. PubMed ID: 35468792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-Cas12a nucleases function with structurally engineered crRNAs: SynThetic trAcrRNA.
    Jedrzejczyk DJ; Poulsen LD; Mohr M; Damas ND; Schoffelen S; Barghetti A; Baumgartner R; Weinert BT; Warnecke T; Gill RT
    Sci Rep; 2022 Jul; 12(1):12193. PubMed ID: 35842430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing the Endogenous CRISPR-Cas9 System for High-Efficiency Genome Editing in
    Gu S; Zhang J; Li L; Zhong J
    ACS Synth Biol; 2022 Dec; 11(12):4031-4042. PubMed ID: 36414383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast.
    Zhang XR; He JB; Wang YZ; Du LL
    G3 (Bethesda); 2018 May; 8(6):2067-2077. PubMed ID: 29703785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.